Ionis Pharmaceuticals, Inc. (IONS)
76.82
+0.06
(+0.08%)
USD |
NASDAQ |
Apr 15, 16:00
76.82
0.00 (0.00%)
Pre-Market: 08:18
Ionis Pharmaceuticals Research and Development Expense (Quarterly) : 279.36M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Mirum Pharmaceuticals, Inc. | 51.03M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |